TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12740744

Group type: EXPERIMENTAL
Intervention: Tennis training and competition
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: 1 hour of tennis play
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Previous day and week training
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Exercise-induced suppression of salivary IgA
Number of subjects: 17
Study: 11000297

Group type: EXPERIMENTAL
Intervention: Fast spin-echo (FSE) sequence with effective TE of 20 ms
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional spin-echo (CSE) sequence
Number of subjects: 100
Study: 8982148

Group type: EXPERIMENTAL
Intervention: Hydroxyurea (HU) therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 1597230

Group type: EXPERIMENTAL
Intervention: Nitroglycerin infusion (100 micrograms.min‐1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6233404

Group type: EXPERIMENTAL
Intervention: Tc-99m HMDP
Number of subjects: 28

Group type: COMPARATOR
Intervention: Tc-99m MDP
Number of subjects: 28
Study: 30312459

Group type: EXPERIMENTAL
Intervention: Living Better Beyond Pain (LBBP) program
Number of subjects: 35
Study: 31374191

Group type: EXPERIMENTAL
Intervention: Monthly coaching by physiotherapists encouraging 30 minutes of daily physical activity and 45-60 minutes of weekly exercise
Number of subjects: 186
Study: 25638011

Group type: EXPERIMENTAL
Intervention: secukinumab 30 mg/kg IV
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: secukinumab 10 mg/kg IV
Number of subjects: 37

Group type: COMPARATOR
Intervention: secukinumab 300 mg SC
Number of subjects: 37
Study: 23649562

Group type: EXPERIMENTAL
Intervention: Loving-kindness meditation intervention group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 0
Study: 21617456

Group type: EXPERIMENTAL
Intervention: Arginine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Alanine (control)
Number of subjects: 20
Study: 18830553

Group type: EXPERIMENTAL
Intervention: Preemptive local analgesia (PLA) with 20 ml of 0.5% bupivacaine with 1:200,000 epinephrine
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Preemptive local analgesia (PLA)
Number of subjects: 90
Study: 16984502

Group type: EXPERIMENTAL
Intervention: Pegylated-interferon-alpha2a plus ribavirin
Number of subjects: 161

Group type: COMPARATOR
Intervention: Pegylated-interferon-alpha2a plus ribavirin and amantadine
Number of subjects: 161
Study: 15035516

Group type: EXPERIMENTAL
Intervention: 150 mL of iopamidol (300 mgI/mL) at 5 mL/second
Number of subjects: 23

Group type: COMPARATOR
Intervention: 100 mL of iopamidol (370 mgI/mL) at 4 mL/second
Number of subjects: 23
Study: 11488732

Group type: EXPERIMENTAL
Intervention: Interstitial radiofrequency therapy (IRFT)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Transurethral resection of the prostate (TURP)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Both IRFT and TURP
Number of subjects: 2
Study: 9743440

Group type: EXPERIMENTAL
Intervention: Nifedipine GITS (30 mg starting dose, 60 mg maintenance dose once daily)
Number of subjects: 6000

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 6000
Study: 8039525

Group type: EXPERIMENTAL
Intervention: Prolonged cognitive task prior to sleep onset
Number of subjects: 14

Group type: COMPARATOR
Intervention: Relaxing condition (staying awake in a relaxed state)
Number of subjects: 14
Study: 2737602

Group type: EXPERIMENTAL
Intervention: Heat-inactivated hepatitis B vaccine with HBsAg complexed by anti-HBs in hepatitis B immunoglobulin at equivalent proportions
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: Heat-inactivated hepatitis B vaccine with HBsAg complexed by anti-HBs in hepatitis B immunoglobulin at 10-fold antigen excess
Number of subjects: 305

Group type: COMPARATOR
Intervention: Control vaccine with standard dosage of HBsAg (3 micrograms)
Number of subjects: 305
Study: 29625841

Group type: EXPERIMENTAL
Intervention: Adjuvant gemcitabine 1000 mg/m2 on days 1, 8, 15 every 4 weeks for six cycles (group A)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Adjuvant PEXG (cisplatin 30 mg/m2, epirubicin 30 mg/m2, and gemcitabine 800 mg/m2 on days 1 and 15 every 4 weeks and capecitabine 1250 mg/m2 on days 1-28) (group B)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Three cycles of PEXG before and three cycles after surgery (group C)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Toxicity analysis for all groups
Number of subjects: 88
Study: 28126156

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass graft (CABG)
Number of subjects: 1550

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 1550

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 1550
Study: 26328588

Group type: EXPERIMENTAL
Intervention: Proton pump inhibitor (PPI) therapy with 40 mg pantoprazole b.i.d.
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 24
Study: 22699302

Group type: EXPERIMENTAL
Intervention: Anamorelin 50 mg/day
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 21714844

Group type: EXPERIMENTAL
Intervention: Structured educational nursing intervention (6 hours of instruction and 2 hours of clinical demonstration)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Usual staff development activities (Control group)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Structured educational nursing intervention
Number of subjects: 192
Study: 18292424

Group type: EXPERIMENTAL
Intervention: Flash group (photographed with a flash of light)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Distraction group (photographed without a flash of light)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Flash group
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Distraction group
Number of subjects: 90
Study: 17238666

Group type: EXPERIMENTAL
Intervention: Automated prompts delivered via mobile devices to monitor exercise and symptoms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Usability of mobile devices for monitoring
Number of subjects: 0
Study: 12897327

Group type: EXPERIMENTAL
Intervention: Gefitinib 250 mg/day
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Gefitinib 500 mg/day
Number of subjects: 216

Group type: COMPARATOR
Intervention: Gefitinib (250 mg or 500 mg daily)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Gefitinib
Number of subjects: 216
Study: 11502792

Group type: COMPARATOR
Intervention: 0 mg oral androstenedione
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 100 mg oral androstenedione
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 300 mg oral androstenedione
Number of subjects: 37
Study: 9132735

Group type: EXPERIMENTAL
Intervention: Five-step Approach
Number of subjects: 73

Group type: COMPARATOR
Intervention: Nonstrategy
Number of subjects: 73
Study: 8321259

Group type: EXPERIMENTAL
Intervention: Intrathecal chemotherapy during the first year; cranial irradiation and intrathecal chemotherapy one year after remission for high-risk patients
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: Intrathecal injections of chemotherapeutic agents and cranial irradiation for patients with central nervous system leukemia at diagnosis
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: Presence of cerebrospinal fluid blast cells with fewer than 5 leukocytes per microliter
Number of subjects: 351
Study: 2455140

Group type: EXPERIMENTAL
Intervention: Nifedipine plus mefruside (1 q.d.)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Nifedipine plus placebo
Number of subjects: 24
Study: 29673356

Group type: EXPERIMENTAL
Intervention: Women with fibromyalgia (FM)
Number of subjects: 118
Study: 26813242

Group type: EXPERIMENTAL
Intervention: Ball attachments
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Conus attachments
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 25
Study: 24755566

Group type: EXPERIMENTAL
Intervention: Routine Acupuncture (RA) + Time Method Acupuncture (TA)
Number of subjects: 60
Study: 23349557

Group type: EXPERIMENTAL
Intervention: 600 mg of ALA after 10 days of oral ingestion (Group C)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 600 mg of ALA (single dose) (Group B)
Number of subjects: 30

Group type: COMPARATOR
Intervention: 90 dB HL 3 kHz pure tone for 10 min (Group A)
Number of subjects: 30
Study: 21140562

Group type: EXPERIMENTAL
Intervention: Cytoflavin as a supporting drug in CAF chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: CAF chemotherapy
Number of subjects: 0
Study: 17622283

Group type: EXPERIMENTAL
Intervention: Cadence of 50 r.min-1
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cadence of 90 r.min-1
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cadence of 50 and 70 r.min-1
Number of subjects: 10
Study: 15716608

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Azathioprine
Number of subjects: 0
Study: 11982877

Group type: EXPERIMENTAL
Intervention: Chest tube placement
Number of subjects: 72

Group type: COMPARATOR
Intervention: Venous catheter insertion
Number of subjects: 72
Study: 11938852

Group type: EXPERIMENTAL
Intervention: Preoperative radiation plus surgery (RS)
Number of subjects: 370

Group type: COMPARATOR
Intervention: Surgery alone (SA)
Number of subjects: 370

Group type: COMPARATOR
Intervention: Surgery alone (SA) for stage III and IV supraglottic carcinomas
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Preoperative radiation plus surgery (RS) for stage III and IV supraglottic carcinomas
Number of subjects: 370

Group type: COMPARATOR
Intervention: Surgery alone (SA) for T3 and T4 supraglottic carcinomas
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Preoperative radiation plus surgery (RS) for T3 and T4 supraglottic carcinomas
Number of subjects: 370
Study: 7631729

Group type: EXPERIMENTAL
Intervention: Kelly plication
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Modified Pereyra needle suspension
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Burch urethropexy
Number of subjects: 127
Study: 1497046

Group type: EXPERIMENTAL
Intervention: Home uterine activity monitoring and daily midwife contact
Number of subjects: 168

Group type: COMPARATOR
Intervention: Standard care for high-risk women (control)
Number of subjects: 168
Study: 350129

Group type: EXPERIMENTAL
Intervention: Amantadine therapy
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Amantadine alone or added to stable dose of levodopa
Number of subjects: 94

Group type: COMPARATOR
Intervention: Levodopa alone or added to stable dose of amantadine
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: 300 mg of amantadine a day
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: 200 mg of amantadine a day
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Amantadine
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: All groups combined
Number of subjects: 94
Study: 30242235

Group type: EXPERIMENTAL
Intervention: Intervention group (education and nutritional counseling program)
Number of subjects: 275
Study: 28692703

Group type: EXPERIMENTAL
Intervention: Feedback from faculty staff physicians
Number of subjects: 40

Group type: COMPARATOR
Intervention: Feedback from patient instructors (PIs)
Number of subjects: 40
Study: 26115203

Group type: EXPERIMENTAL
Intervention: Gastroretentive gabapentin (G‐GR) 1,800 mg once daily
Number of subjects: 719

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 719
Study: 24118500

Group type: EXPERIMENTAL
Intervention: Supervised injectable heroin treatment
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Supervised injectable methadone treatment
Number of subjects: 127

Group type: COMPARATOR
Intervention: Optimised oral methadone treatment
Number of subjects: 127
Study: 21305524

Group type: EXPERIMENTAL
Intervention: golimumab 50 mg plus MTX
Number of subjects: 1081

Group type: EXPERIMENTAL
Intervention: golimumab 100 mg plus MTX
Number of subjects: 1081

Group type: COMPARATOR
Intervention: placebo plus MTX
Number of subjects: 1081
Study: 19489188

Group type: EXPERIMENTAL
Intervention: New toothpaste containing 8.0% arginine, calcium carbonate, and 1450 ppm fluoride as sodium monofluorophosphate (MFP)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Commercial sensitive toothpaste containing 2% potassium ion and 1450 ppm fluoride as sodium fluoride (NaF)
Number of subjects: 80
Study: 17061598

Group type: EXPERIMENTAL
Intervention: Multi-injection thoracic paravertebral anesthesia (TPVA) with intravenous sedation
Number of subjects: 180

Group type: COMPARATOR
Intervention: Traditional multicomponent general anesthesia
Number of subjects: 180
Study: 16915030

Group type: EXPERIMENTAL
Intervention: 150 mg/day irbesartan
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 12820855

Group type: EXPERIMENTAL
Intervention: Conventional X-ray examination
Number of subjects: 47

Group type: COMPARATOR
Intervention: Standard dose CT examination
Number of subjects: 47
Study: 10366086

Group type: EXPERIMENTAL
Intervention: EXCIMER (193-nm Meditec excimer laser)
Number of subjects: 179

Group type: COMPARATOR
Intervention: CONTROL (hand-held motor trephine)
Number of subjects: 179
Study: 7718370

Group type: EXPERIMENTAL
Intervention: Patient-controlled analgesia (PCA)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Intramuscular injections (IMI)
Number of subjects: 110
Study: 2045142

Group type: EXPERIMENTAL
Intervention: Slow Sodium (100 mmol sodium/day)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Slow Sodium placebo
Number of subjects: 21
Study: 7257433

Group type: EXPERIMENTAL
Intervention: Metronidazole preoperative preparation
Number of subjects: 0
Study: 31633313

Group type: EXPERIMENTAL
Intervention: Healthy low-fat diet
Number of subjects: 609

Group type: EXPERIMENTAL
Intervention: Healthy low-carbohydrate diet
Number of subjects: 609
Study: 28737425

Group type: EXPERIMENTAL
Intervention: Lingual orthodontics (20 patients)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional buccal orthodontics (20 patients)
Number of subjects: 40
Study: 25592010

Group type: EXPERIMENTAL
Intervention: Monosodium glutamate (MSG) 150mg/kg
Number of subjects: 32

Group type: COMPARATOR
Intervention: NaCl (control) 24mg/kg
Number of subjects: 32
Study: 23598172

Group type: EXPERIMENTAL
Intervention: Axitinib (5 mg twice daily)
Number of subjects: 723

Group type: COMPARATOR
Intervention: Sorafenib (400 mg twice daily)
Number of subjects: 723
Study: 20975285

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) with high MPL content
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) with lower MPL content
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 18300905

Group type: EXPERIMENTAL
Intervention: Standard open microsurgical discectomy (SOMD)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Minimal access microsurgical discectomy (MAMD)
Number of subjects: 60
Study: 17323729

Group type: EXPERIMENTAL
Intervention: Sandblasting of a specific area of the denture
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 14
Study: 12867568

Group type: EXPERIMENTAL
Intervention: Early high-dose steroids and nasal CPAP ventilation
Number of subjects: 190

Group type: COMPARATOR
Intervention: Other three treatment groups (not specified)
Number of subjects: 190
Study: 10711914

Group type: EXPERIMENTAL
Intervention: Program for relapse prevention (PRP)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 82
Study: 8613546

Group type: EXPERIMENTAL
Intervention: GHRH-Ant 400 microgram/kg i.v.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 0
Study: 1343282

Group type: EXPERIMENTAL
Intervention: Manidipine 10 mg/day
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Delapril 30 mg/day
Number of subjects: 20
Study: 6429694

Group type: EXPERIMENTAL
Intervention: Smoking during high-arousal situations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Smoking in females
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Smoking in males
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Deprivation in smokers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Smoking in high-arousal situations
Number of subjects: 0

Group type: COMPARATOR
Intervention: Smoking vs. nonsmokers
Number of subjects: 0
Study: 31432074

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 21682

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 21682
Study: 30508898

Group type: EXPERIMENTAL
Intervention: Funnel covered stents (44 cases)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Individualized stents (44 cases)
Number of subjects: 88
Study: 27653814

Group type: EXPERIMENTAL
Intervention: Platelet transfusion 24 h after ticagrelor
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Platelet transfusion 48 h after ticagrelor
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Platelet transfusion 48 h after clopidogrel
Number of subjects: 44

Group type: COMPARATOR
Intervention: No transfusion after clopidogrel
Number of subjects: 44
Study: 24465156

Group type: EXPERIMENTAL
Intervention: MMP (multi‐ingredient pre‐exercise workout supplement blend of creatine, betaine and a dendrobium extract)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: MMP
Number of subjects: 43

Group type: COMPARATOR
Intervention: Comparator
Number of subjects: 43
Study: 23093587

Group type: EXPERIMENTAL
Intervention: Alcohol
Number of subjects: 4680

Group type: EXPERIMENTAL
Intervention: Urinary sodium-to-potassium ratio
Number of subjects: 4680

Group type: EXPERIMENTAL
Intervention: Dietary phosphorus
Number of subjects: 4680

Group type: EXPERIMENTAL
Intervention: Dietary magnesium
Number of subjects: 4680

Group type: EXPERIMENTAL
Intervention: Dietary iron
Number of subjects: 4680

Group type: EXPERIMENTAL
Intervention: Dietary thiamin
Number of subjects: 4680

Group type: EXPERIMENTAL
Intervention: Dietary folacin
Number of subjects: 4680

Group type: EXPERIMENTAL
Intervention: Dietary riboflavin
Number of subjects: 4680
Study: 20733135

Group type: EXPERIMENTAL
Intervention: OGX-011 with docetaxel/prednisone (arm A)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Docetaxel/prednisone without OGX-011 (arm B)
Number of subjects: 82
Study: 18724865

Group type: EXPERIMENTAL
Intervention: Periodontal therapy with or without the use of antibiotics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Implant therapy in subjects with diabetes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Poorly controlled diabetes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Controlled diabetes
Number of subjects: 0
Study: 15842586

Group type: EXPERIMENTAL
Intervention: K-Canrenoate (200 mg/day for 6 months)
Number of subjects: 22

Group type: COMPARATOR
Intervention: No-drug treatment (control group)
Number of subjects: 22
Study: 14699226

Group type: EXPERIMENTAL
Intervention: Dexamethasone (8 mg) and Ondansetron (4 mg)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Dexamethasone (8 mg) and Metoclopramide (10 mg)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Saline I.V.
Number of subjects: 120
Study: 12114161

Group type: EXPERIMENTAL
Intervention: Telephone consultation with digital images
Number of subjects: 12

Group type: COMPARATOR
Intervention: Telephone consultation without digital images
Number of subjects: 12
Study: 10629548

Group type: EXPERIMENTAL
Intervention: High eosinophil counts
Number of subjects: 584

Group type: EXPERIMENTAL
Intervention: High mast cell counts
Number of subjects: 584

Group type: EXPERIMENTAL
Intervention: Advanced Dukes' stage
Number of subjects: 584

Group type: EXPERIMENTAL
Intervention: High age
Number of subjects: 584
Study: 7568634

Group type: EXPERIMENTAL
Intervention: Pindolol pretreatment
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: d‐fenfluramine (d‐FEN)
Number of subjects: 10
Study: 2258632

Group type: EXPERIMENTAL
Intervention: Human fibroblast interferon (3 X 10(6) units)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Intralesional interferon beta
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Subcutaneous interferon beta
Number of subjects: 80
Study: 6455048

Group type: EXPERIMENTAL
Intervention: Sodium fluoride, calcium, and calciferol
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 29679659

Group type: EXPERIMENTAL
Intervention: Emotional contagion (leaders transmitting emotions to followers)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Emotional non‐contagion (followers imitating a facial image)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: High emotional contagion (HEC) group
Number of subjects: 64

Group type: COMPARATOR
Intervention: Low emotional contagion (LEC) group
Number of subjects: 64
Study: 28423407

Group type: EXPERIMENTAL
Intervention: Web-mediated follow-up algorithm based on weekly self-scored patient symptoms
Number of subjects: 133

Group type: COMPARATOR
Intervention: Routine follow-up with CT scans scheduled every three to six months
Number of subjects: 133
Study: 25288513

Group type: EXPERIMENTAL
Intervention: 25 g glucose
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo drink
Number of subjects: 48
Study: 25100773

Group type: EXPERIMENTAL
Intervention: Bandage group
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (cold pack)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Impulse compression group
Number of subjects: 58
Study: 22933800

Group type: EXPERIMENTAL
Intervention: Attention to the target with contiguous surround (unsegmented)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Attention to the target with segmented surround (gap or phase offset)
Number of subjects: 0
Study: 19208261

Group type: EXPERIMENTAL
Intervention: 4-month treadmill walking program
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: 2-month treadmill walking program
Number of subjects: 210

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 210
Study: 17301652

Group type: EXPERIMENTAL
Intervention: 30 mg/kg ATP administered through a naso-intestinal tube
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo administered through a naso-intestinal tube
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition (no indomethacin or ATP/placebo)
Number of subjects: 0